News

Pfizer and BioNTech start study to test combined COVID-19 and flu vaccine

By Abigail Adcox
Published November 3, 2022 2:15pm ET
Add Washington Examiner on Google
Pfizer and BioNTech start study to test combined COVID-19 and flu vaccine
FILE - In this Jan. 30, 2012 file photo, boxes of the drug Relpax, made by Pfizer, are displayed in Surfside, Fla. Pfizer reports quarterly results before the market open on Tuesday, Jan. 28, 2014. (AP Photo/Wilfredo Lee, File) | Wilfredo Lee

Pfizer and BioNTech announced Thursday they have begun an early-stage study to test a combination vaccine for COVID-19 and the flu.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 Pfizer research Vaccines